BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
16 results:

  • 1. Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line.
    Cardona-Mendoza A; Fonseca-Benitez A; Buitrago DM; Coy-Barrera E; Perdomo SJ
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117225. PubMed ID: 37797877
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SIRT1 and gynecological malignancies (Review).
    Chen J; Chen H; Pan L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells.
    Matsumoto N; Ebihara M; Oishi S; Fujimoto Y; Okada T; Imamura T
    Sci Rep; 2021 Jan; 11(1):1492. PubMed ID: 33452347
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combinatory treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs cancer Cells.
    Gajda E; Godlewska M; Mariak Z; Nazaruk E; Gawel D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708846
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Potent and Selective Cytotoxic and Anti-inflammatory Gold(III) Compounds Containing Cyclometalated Phosphine Sulfide Ligands.
    Reddy TS; Pooja D; Privér SH; Luwor RB; Mirzadeh N; Ramesan S; Ramakrishna S; Karri S; Kuncha M; Bhargava SK
    Chemistry; 2019 Nov; 25(62):14089-14100. PubMed ID: 31414501
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of B7-H4 in the Progression and Prognosis of cervical Inflammation to cancer After Human Papilloma Virus Infection.
    Qiu F; Yuan C; Xu J; Zhang J; Chen F; Liu D; Zheng B; Li R; Huang X; Xu J
    J Biomed Nanotechnol; 2019 May; 15(5):1043-1051. PubMed ID: 30890234
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapy of cervical cancer using
    Li W; Sun D; Li N; Shen Y; Hu Y; Tan J
    J Int Med Res; 2018 Jun; 46(6):2359-2370. PubMed ID: 29658363
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
    Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
    Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells.
    Lizarraga F; Espinosa M; Ceballos-Cancino G; Vazquez-Santillan K; Bahena-Ocampo I; Schwarz-Cruz Y Celis A; Vega-Gordillo M; Garcia Lopez P; Maldonado V; Melendez-Zajgla J
    Mol Carcinog; 2016 Dec; 55(12):1952-1961. PubMed ID: 26618609
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
    Bhattacharjya S; Roy KS; Ganguly A; Sarkar S; Panda CK; Bhattacharyya D; Bhattacharyya NP; Roychoudhury S
    Mol Cancer; 2015 Feb; 14():42. PubMed ID: 25743594
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
    Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
    Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.
    Candelaria M; de la Cruz-Hernandez E; Taja-Chayeb L; Perez-Cardenas E; Trejo-Becerril C; Gonzalez-Fierro A; Chavez-Blanco A; Soto-Reyes E; Dominguez G; Trujillo JE; Diaz-Chavez J; Duenas-Gonzalez A
    PLoS One; 2012; 7(3):e29181. PubMed ID: 22427797
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
    You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
    Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
    Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
    Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.
    Mizutani T; Ito T; Nishina M; Yamamichi N; Watanabe A; Iba H
    J Biol Chem; 2002 May; 277(18):15859-64. PubMed ID: 11850427
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.